ClinicalTrials.gg
RecruitingNCT07323810Updated Aug 18, 2026

Monitoring the Effect of Mental Fatigue on Physical Performance Using Wearable Sensors and Physiological Parameters

An interventional study of Mental Fatigue in Mental Fatigue, sponsored by Vrije Universiteit Brussel. Recruiting at 1 site in Belgium. Open to participants aged 18 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-18.

Sponsored by Vrije Universiteit Brussel · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Started Dec 2025; still recruiting 11 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years to 35 Years
Sex
All
01

Study summary

Mental fatigue (MF) negatively affects both cognitive and physical performance, increasing the risk of errors in high-stakes environments such as sports and surgery. Traditional methods to assess MF rely on subjective self-report scales, which are prone to bias, or on complex brain measurements (e.g. EEG) that are impractical outside laboratory settings. This study aims to develop a real-time, objective monitoring method for MF using wearable physiological sensors. The study will recruit healthy, trained runners (18-35 years old) who will complete both an MF-inducing cognitive task (Stroop test) and a control condition (watching a documentary) in a randomized, counterbalanced, crossover design. Heart rate variability, respiration rate, and pupil metrics will be continuously recorded using wearable devices. Machine learning models will be used to predict MF-level as well as the effect of MF on physical performance (5-km time trial on a treadmill) using the physiological data as input.

02

Conditions studied

  • Mental Fatigue

Keywords

  • Fatigue
  • Performance
  • Physiology
  • Wearables
03

In context

Mental Fatigue

175 studies on the registry are indexed under Mental Fatigue; 54 are open to participants now.

This study's planned enrollment of 30 is below the median of 45 across 143 interventional studies indexed under Mental Fatigue.

Browse Mental Fatigue studies →

Lead sponsor

Vrije Universiteit Brussel is the lead sponsor of 158 studies on the registry; 43 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Healthy (no neurological, cardiovascular or musculoskeletal disorders of any kind)
  • Male or female
  • No prior knowledge of the concept of MF
  • No medication
  • Non-smoker
  • 18-35 years of age
  • Experienced runners: (≥15km/week and/or ≥2u/week during the last 6 months)

Exclusion criteria

Exclusion Criteria:

  • Injuries in the past 6 months, affecting running performance
  • Suffering from a chronic health condition (could be neurological, cardiovascular, internal or musculoskeletal)
  • Participating in any concomitant care or research trials
  • History of suffering from any mental/psychiatric disorders
  • Use of medication
  • Use of caffeine and heavy efforts 24 hours prior each trial
  • Suffering from colour vision deficiencies
  • Not eating a standardized meal, the morning of each trial and the evening before each trial
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Participant)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Mental Fatigue Condition

    The mental fatigue task will involve a modified Stroop test, adapted from previous research. Words will appear on the screen in 34-point font for 1000 milliseconds, with the inter-stimulus interval personalized based on each participant's Stroop max test performance. Stroop task duration will be 60 minutes for every participant. Participants will be instructed to respond as quickly and accurately as possible.

    Behavioral: Mental Fatigue

  • No intervention
    Control condition

    The control task will consist of watching a pre-approved, emotionally neutral 60-minute documentary.

Interventions

  • BehavioralMental Fatigue

    Mental fatigue (MF) is a psychobiological state characterized by feelings of tiredness and/or a measurable decline in performance following prolonged or intense cognitive activity.

06

What researchers measure

Primary outcomes

  1. Heart rate variability time-domain parameters

    Root mean square of successive differences \[RMSSD\], standard deviation of normal-to-normal intervals \[SDNN\] in milliseconds.

    Time frame: Continuously during the cognitive intervention and control condition on the study day (approximately 75 minutes).

  2. Heart rate variability frequency-domain parameters

    Low-frequency (LF), High-frequency (HF) in milliseconds squared (ms²) and Low/high-frequency ratio \[LF/HF\]

    Time frame: Continuously during the cognitive intervention and control condition on the study day (approximately 75 minutes).

  3. Respiration rate

    Respiration rate (RR) will be measured as the number of breaths per minute (breaths/min)

    Time frame: Continuously during the cognitive intervention and control condition on the study day (approximately 75 minutes).

  4. Pupil diameter

    Pupil diameter (PD) will be measured in millimeters (mm) as an index of autonomic nervous system activity.

    Time frame: Continuously during the cognitive intervention and control condition on the study day (approximately 75 minutes).

  5. Blinking rate

    Blinking rate (BR) will be measured as the number of spontaneous blinks per minute (blinks/min)

    Time frame: Continuously during the cognitive intervention and control condition on the study day (approximately 75 minutes).

  6. Eyelid opening

    Eyelid opening (EO) will be measured as the vertical distance between the upper and lower eyelid in millimeters (mm).

    Time frame: Continuously during the cognitive intervention and control condition on the study day (approximately 75 minutes).

  7. Cognitive Performance Accuracy

    Cognitive performance will be evaluated using a Go/No-Go task. The task begins with a general instruction screen, followed by the simultaneous presentation of two types of stimuli: a Go or No-Go signal and a left or right directional indicator. This results in four possible combinations: GoRight, GoLeft, NoGoRight, and NoGoLeft. When a Go signal appears, participants must respond by pressing the arrow key corresponding to the left or right direction. In contrast, when a No-Go signal is displayed, participants must withhold any response, regardless of the directional cue. This paradigm is designed to assess attention, response inhibition, working memory, and executive functions, all of which are known to be negatively affected by MF. Accuracy in percentage (%) of correct answers on this Go/No-Go task as well as accuracy during the Stroop intervention task will be measured.

    Time frame: At baseline (pre-intervention), during the 60-minute cognitive intervention, and immediately after completion of the intervention on the study day (approximately 70 minutes total).

  8. Cognitive Performance Reaction Time

    Cognitive performance will be evaluated using a Go/No-Go task. The task begins with a general instruction screen, followed by the simultaneous presentation of two types of stimuli: a Go or No-Go signal and a left or right directional indicator. This results in four possible combinations: GoRight, GoLeft, NoGoRight, and NoGoLeft. When a Go signal appears, participants must respond by pressing the arrow key corresponding to the left or right direction. In contrast, when a No-Go signal is displayed, participants must withhold any response, regardless of the directional cue. This paradigm is designed to assess attention, response inhibition, working memory, and executive functions, all of which are known to be negatively affected by MF. Reaction time (RT) will be measured in milliseconds (ms) as the latency between stimulus onset and the participant's behavioral response (button press) on the Go/No-Go task and during the Stroop intervention task.

    Time frame: At baseline (pre-intervention), during the 60-minute cognitive intervention, and immediately after completion of the intervention on the study day (approximately 70 minutes total).

  9. Physical performance: Time to Completion

    Participants will perform a 5-km running time trial on a treadmill to assess endurance performance under MF. The treadmill will be set at a 1% gradient, following established protocols to replicate outdoor running conditions. Before beginning the time trial, participants will complete a standardized warm-up for 5 minutes. To maintain self-paced running conditions, participants will receive real-time feedback on the distance covered but will not be provided with information about running speed or elapsed time. Researchers will remain present but will not offer verbal encouragement or pacing cues to ensure that the effort remains internally regulated. Once the 5-km distance is completed, participants will immediately stop running and step onto the treadmill's side platforms. The total time elapsed will be recorded.

    Time frame: Immediately after completion of the 60-minute cognitive intervention, during a single 5-km treadmill time trial on the study day (approximately 20 minutes).

Secondary outcomes

  1. Subjective feeling of Mental Fatigue

    The Mental Fatigue Visual Annalogue Scale (0-10cm) will assess how mentally fatigued the participant is feeling (100 point VAS scale), and ranges from 'not at all' to 'completely exhausted'.

    Time frame: At baseline (pre-intervention), every 5 minutes during the 60-minute cognitive intervention, and immediately after completion of the intervention on the study day.

  2. Mood

    The Brunel Mood Scale (BRUMS) will be used to indicate mood, and serve as a control measure for both arousal as well as boredom. It features 24 mood descriptors (divided into 6 subscales (i.e. anger, confusion, depression, fatigue, tension and vigor)), where participants have to give a value for every mood on a 5-point Likert scale (i.e. 0=not at all to 4 = extremely) responding to the question: "how do you feel right now?"

    Time frame: At baseline, prior to the start of each experimental and control trial on the study day.

  3. Motivation

    Moti-VAS: Motivation will be assessed using a VAS. Participants will be asked "How motivated do you feel for the upcoming task", and will be instructed to rate their answer on a 10cm line, with the statements "not at all" and "extremely motivated" at opposite ends of this line.

    Time frame: At baseline (pre-intervention) and immediately after completion of the 60-minute cognitive intervention on the study day.

  4. Sleepiness

    The Karolinska Sleepiness Scale (KSS) will be conducted. This 10-point scale measures the subjective level of sleepiness and goes from 1 = 'extremely alert' to 10 = 'extremely sleepy, falls asleep all the time'.

    Time frame: At baseline (pre-intervention) and immediately after completion of the 60-minute cognitive intervention on the study day.

  5. Physical fatigue

    To measure subjective feeling of physical fatigue, a P-VAS scale (0-10 cm) will be administered before each physical performance test to check the level of subjective physical fatigue of the participants. Participants will be asked to rate their general physical fatigue on a 10 cm line ranging from "not at all" to "completely exhausted".

    Time frame: Immediately prior to the physical performance test on the study day.

  6. Perceived physical exertion

    Rating of Perceived Exertion (RPE) will be measured using the Borg CR100® scale, which ranges from 0 to 100, with 0 representing "no exertion at all" and 100 representing "maximal exertion". Higher scores indicate greater perceived effort. Participants will be asked to provide an RPE rating at the end of each kilometre during the 5-km time trial.

    Time frame: During the 5-km treadmill time trial, assessed at the end of each kilometer on the study day.

  7. Pacing

    Pacing will be assessed as the pattern of speed regulation across the 5-km time trial. Running speed (km/h) will be recorded continuously and summarized per kilometre to characterize pacing strategy (positive, negative, or even pacing). Relative speed will also be expressed as a percentage of average trial speed. Alongside total completion time, pacing will serve as an indicator of how participants distribute effort under self-paced running conditions. Participants will be asked every kilometer how fast they think they are running at that moment to verify any discrepancies with their actual running speed and observe whether there is a learning or condition effect.

    Time frame: During the 5-km treadmill time trial, assessed at the end of each kilometer on the study day.

07

Study locations

1 of 1 sites recruiting
  • Brussels Labo voor Inspanning en Topsport
    Brussels, 1050, Belgium
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Dec 2025 (actual). Primary completion is estimated for Sep 2026, 9 months after the start.

Of 80 non-industry interventional studies with no phase under Mental Fatigue, half reached primary completion within 9 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 23. This study's planned 9 months is close to that.

Counting every sponsor, half of 92 studies reached it within 8 months; a quarter within 3 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 22, 2025
First posted
Jan 7, 2026
StartActual
Dec 3, 2025
Primary completionEst.
Sep 2026
CompletionEst.
Sep 2026
Last update
Aug 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 18, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07323810
Responsible party
Bart Roelands (Professor Doctor, Vrije Universiteit Brussel) — Principal investigator
First posted
Jan 7, 2026
Start date
Dec 3, 2025
Primary completion
Sep 2026 (estimated)
Completion
Sep 2026 (estimated)
Last update
Aug 18, 2026

Study contacts

Emilie Schampheleer, Msc
Contact
emilie.schampheleer@vub.be
26292222 ext. +32

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion